This cohort study assesses the occurrence of overall mortality, cardiovascular mortality, acute myocardial infarction, stroke, and hospitalization for congestive heart failure among adults with type 2 diabetes receiving long-acting insulin alone vs long- plus short-acting insulin treatment. This evidence concerns the gene INS and congestive heart failure.